Intellia Therapeutics (NTLA)

Download button icon Download

Intellia Therapeutics (NTLA): Signals

No data currently available.

data-ad-format="auto">

Explore Compare Share

TECHNICAL ANALYSIS SUMMARY

Intellia Therapeutics current pivot point (Woodie) is:
$30.223.

The current resistance levels are:
(R1) $30.896
(R2) $32.273

The current support levels are:
(S1) $28.846
(S2) $28.173



One of the key differences in calculating Woodies Pivot Point to other pivot points is that the current sessions open price is used in the PP formula with the previous sessions high and low.

Calculation: Woodie Pivot Point:
1) R2 = PP + High – Low;
2) R1 = (2 X PP) – Low;
3) PP = (H + L + 2C) / 4;
4) S1 = (2 X PP) – High;
5) S2 = PP – High + Low – Closing Price – High – Low;


PROFILE: Intellia Therapeutics (NTLA)


Stock Exchange: NASDAQ
Company: Intellia Therapeutics
Ticker Codes: | NTLA | NASDAQ:NTLA |

About Intellia Therapeutics (NASDAQ:NTLA):

Intellia Therapeutics, Inc., a gene editing company, focuses on the development of therapeutics utilizing a biological tool known as the CRISPR/Cas9 system. The company develops in vivo programs focused on liver diseases, including transthyretin amyloidosis, alpha-1 antitrypsin deficiency, hepatitis B virus, and inborn errors of metabolism programs. Its ex vivo pipeline includes proprietary programs focused on developing engineered cell therapies to treat various oncological and autoimmune diseases; and partnered programs focused on chimeric antigen receptor T cells and hematopoietic stem cells. Intellia Therapeutics, Inc. has collaboration agreement with Novartis Institutes for BioMedical Research, Inc.; Regeneron Pharmaceuticals, Inc.; and Caribou Biosciences, Inc. The company was formerly known as AZRN, Inc. and changed its name to Intellia Therapeutics, Inc. in July 2014. Intellia Therapeutics, Inc. was founded in 2014 and is headquartered in Cambridge, Massachusetts.

Top 10:

Woodie Pivot Point

Download button icon Download
Company Close Change (%) Volume Value Signal
RIGL Rigel Pharmaceutical 3.41 6.2 6,196,440 2.83 NEUTRAL
PGNX Progenics Pharmaceuticals 5.88 4.8 3,382,962 19.5 NEUTRAL
PLSE Pulse Biosciences 14.59 3.1 61,433 14.28 NEUTRAL
ANAB Anaptysbio 88.35 2.7 370,797 8.2 NEUTRAL
KTOS Kratos Defense & Security Solutions 14.48 2.7 1,758,654 33.67 NEUTRAL
SVA Sinovac Biotech 7.56 2.2 38,286 63.81 NEUTRAL
CLLS Cellectis 28.16 2.1 388,817 103.68 NEUTRAL
USCR U S Concrete Inc 51.15 1.8 585,162 86.56 NEUTRAL
BLDP Ballard Power Systems 3.83 1.6 1,498,986 6.64 NEUTRAL
AAL American Airlines 40.32 1.5 5,064,270 79.68 NEUTRAL
back to top